ABL Bio Inc. (KOSDAQ:298380)
34,450
+750 (2.23%)
Mar 31, 2025, 3:30 PM KST
ABL Bio Revenue
In the year 2024, ABL Bio had annual revenue of 33.40B KRW, down -49.04%. ABL Bio had revenue of 9.09B in the quarter ending December 31, 2024, with 13.52% growth.
Revenue
33.40B
Revenue Growth
-49.04%
P/S Ratio
49.53
Revenue / Employee
327.48M
Employees
102
Market Cap
1,671.79B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 33.40B | -32.14B | -49.04% |
Dec 31, 2023 | 65.55B | -1.75B | -2.61% |
Dec 31, 2022 | 67.30B | 61.97B | 1,162.19% |
Dec 31, 2021 | 5.33B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition